TomoTherapy inks deal with Nucletron, allowing sales Down Under

Radiation therapy systems provider TomoTherapy has entered into a distribution agreement with radiation oncology solutions provider Nucletron.

The partnership will allow for the expansion of TomoTherapys’ radiation products into New Zealand and Australia, beginning with a contract by Queensland Health to employ the TomoTherapy Hi-Art system at Royal Brisbane & Women’s Hospital in Australia, said the Madison, Wis.-based company.

Around the web

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.